Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Recommendation of “Buy” by Brokerages
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in […]
Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight analysts that are presently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation. The average 12-month target price among brokerages that have issued a report on the stock in […]
